Advancing TB Treatment: Role of flexiVent in Evaluating Bacteriophage Therapy
A recent study by Yang, F., et al (2024) has explored the potential of bacteriophage therapy for treating multi-drug resistant Mycobacterium tuberculosis (Mtb) infections
Lung Function in Conscious Subjects
Viruses are constantly changing through mutation, and currently, there are several variants of the SARS-CoV-2 virus that causes COVID-19.
The Relationship Between e-Cigarette Exposure, Sex Steroids, and COVID-19
Throughout the global COVID-19 pandemic, there has been a noticeably higher mortality rate in males compared to females. Though the mechanism that causes this remains unknown, Dr. Sharma and Dr. Zeki hypothesize
Getting Ahead of COVID-19 Variants
Viruses are constantly changing through mutation, and currently, there are several variants of the SARS-CoV-2 virus that causes COVID-19.
Translational Preclinical Models of COVID-19
In May 2021, SCIREQ had the pleasure of hosting a virtual panel discussion with leading preclinical infectious disease researchers focusing on Preclinical Models of COVID-19.
COVID-19 Research at ATS 2021
The SCIREQ team attended Experimental Biology (EB) 2021 in April! This year, the team virtually sat in on several exciting sessions touching on topics
Catch Up on What We Learned At EB 2021!
The SCIREQ team attended Experimental Biology (EB) 2021 in April! This year, the team virtually sat in on several exciting sessions touching on topics
New Insights From Keystone eSymposia- COVID-19 One Year Later
This February, Keystone held a virtual conference that discussed SARS-CoV-2 transmissibility, immune response, and updates on vaccines and treatments.
vivoFlow for Preclinical SARS-CoV-2 Hamster Studies
As in humans, the Angiotensin I Converting Enzyme 2 (ACE2) receptors of hamsters naturally permit binding of the SARS-CoV-2 virus spike protein. This suggests that hamsters are an important
COVID-19, Vaping, and EVALI
COVID-19 has rapidly spread throughout the world and was declared a pandemic in March of 2020. Currently, there is no clinically validated treatment or vaccine for COVID-19.